Literature DB >> 21865443

Recent advances in the molecular and cellular biology of bunyaviruses.

Cheryl T Walter1, John N Barr1.   

Abstract

The family Bunyaviridae of segmented, negative-stranded RNA viruses includes over 350 members that infect a bewildering variety of animals and plants. Many of these bunyaviruses are the causative agents of serious disease in their respective hosts, and are classified as emerging viruses because of their increased incidence in new populations and geographical locations throughout the world. Emerging bunyaviruses, such as Crimean-Congo hemorrhagic fever virus, tomato spotted wilt virus and Rift Valley fever virus, are currently attracting great interest due to migration of their arthropod vectors, a situation possibly linked to climate change. These and other examples of continued emergence suggest that bunyaviruses will probably continue to pose a sustained global threat to agricultural productivity, animal welfare and human health. The threat of emergence is particularly acute in light of the lack of effective preventative or therapeutic treatments for any of these viruses, making their study an important priority. This review presents recent advances in the understanding of the bunyavirus life cycle, including aspects of their molecular, cellular and structural biology. Whilst special emphasis is placed upon the emerging bunyaviruses, we also describe the extensive body of work involving model bunyaviruses, which have been the subject of major contributions to our overall understanding of this important group of viruses.

Entities:  

Mesh:

Year:  2011        PMID: 21865443     DOI: 10.1099/vir.0.035105-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  92 in total

1.  Genetic characterization of an atypical Schmallenberg virus isolated from the brain of a malformed lamb.

Authors:  Marcel Hulst; Jeroen Kortekaas; Renate Hakze-van der Honing; Stéphanie Vastenhouw; Jan Cornellissen; Kees van Maanen; Alex Bossers; Frank Harders; Norbert Stockhofe; Wim van der Poel
Journal:  Virus Genes       Date:  2013-08-31       Impact factor: 2.332

2.  Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.

Authors:  John C Morrill; Richard C Laughlin; Nandadeva Lokugamage; Jing Wu; Roberta Pugh; Pooja Kanani; L Garry Adams; Shinji Makino; C J Peters
Journal:  Vaccine       Date:  2013-08-27       Impact factor: 3.641

3.  Genome-wide small interfering RNA screens reveal VAMP3 as a novel host factor required for Uukuniemi virus late penetration.

Authors:  Roger Meier; Andrea Franceschini; Peter Horvath; Marilou Tetard; Roberta Mancini; Christian von Mering; Ari Helenius; Pierre-Yves Lozach
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

4.  The first phlebo-like virus infecting plants: a case study on the adaptation of negative-stranded RNA viruses to new hosts.

Authors:  Beatriz Navarro; Maria Minutolo; Angelo De Stradis; Francesco Palmisano; Daniela Alioto; Francesco Di Serio
Journal:  Mol Plant Pathol       Date:  2017-10-04       Impact factor: 5.663

5.  Structural basis for encapsidation of genomic RNA by La Crosse Orthobunyavirus nucleoprotein.

Authors:  Juan Reguera; Hélène Malet; Friedemann Weber; Stephen Cusack
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

Review 6.  Viruses and antiviral immunity in Drosophila.

Authors:  Jie Xu; Sara Cherry
Journal:  Dev Comp Immunol       Date:  2013-05-13       Impact factor: 3.636

7.  Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis.

Authors:  Brooke Harmon; Benjamin R Schudel; Dianna Maar; Carol Kozina; Tetsuro Ikegami; Chien-Te Kent Tseng; Oscar A Negrete
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

8.  Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein.

Authors:  S M de Boer; J Kortekaas; L Spel; P J M Rottier; R J M Moormann; B J Bosch
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

9.  Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines.

Authors:  Heike Hofmann; Xingxing Li; Xiaoai Zhang; Wei Liu; Annika Kühl; Franziska Kaup; Samantha S Soldan; Francisco González-Scarano; Friedemann Weber; Yuxian He; Stefan Pöhlmann
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

10.  Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.

Authors:  John C Morrill; Richard C Laughlin; Nandadeva Lokugamage; Roberta Pugh; Elena Sbrana; William J Weise; L Garry Adams; Shinji Makino; C J Peters
Journal:  Vaccine       Date:  2012-11-12       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.